http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005037212-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4643ee57ec92279c51e17751ae896eed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20f9ead623313f8c91c145cd5b4fc776
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42
filingDate 2004-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4280aae829195565dae4aa3a9957491
publicationDate 2005-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005037212-A3
titleOfInvention Treatment of chemical dependency with substantially nonaddicting normorphine and norcodeine derivatives
abstract A method is provided for treating a drug-dependent individual so as to effect withdrawal from a drug of abuse, e.g., an opiate such as heroin or oxycodone, a stimulant such as cocaine, or alcohol. The method involves substitution therapy wherein a substantially nonaddicting normorphine or norcodeine derivative is substituted for the drug of abuse. The active agent has the structure of formula (I) wherein: R is H, alkyl, or acyl; X is CH(OR') or C=O, wherein Wis H or acyl; a is an optional double bond, with the proviso that when a is present, then X is necessarily CH(OH), or an acid addition salt thereof, wherein preferred such agent s are in a stereoisomerically pure form that corresponds to that of N-[(IR)-1-cyclopropylethyl]-normorphine (1) which melts at approximately 188'C-189'C.
priorityDate 2003-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4218454-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4948803-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5366979-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226491901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226491902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395100
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54373571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID430245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9925873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414253

Total number of triples: 47.